Przejdź do zawartości
Merck

Systematic alteration of in vitro metabolic environments reveals empirical growth relationships in cancer cell phenotypes.

Cell reports (2021-01-21)
Karl Kochanowski, Timur Sander, Hannes Link, Jeremy Chang, Steven J Altschuler, Lani F Wu
ABSTRAKT

Cancer cells, like microbes, live in complex metabolic environments. Recent evidence suggests that microbial behavior across metabolic environments is well described by simple empirical growth relationships, or growth laws. Do such empirical growth relationships also exist in cancer cells? To test this question, we develop a high-throughput approach to extract quantitative measurements of cancer cell behaviors in systematically altered metabolic environments. Using this approach, we examine relationships between growth and three frequently studied cancer phenotypes: drug-treatment survival, cell migration, and lactate overflow. Drug-treatment survival follows simple linear growth relationships, which differ quantitatively between chemotherapeutics and EGFR inhibition. Cell migration follows a weak grow-and-go growth relationship, with substantial deviation in some environments. Finally, lactate overflow is mostly decoupled from growth rate and is instead determined by the cells' ability to maintain high sugar uptake rates. Altogether, this work provides a quantitative approach for formulating empirical growth laws of cancer.

MATERIAŁY
Numer produktu
Marka
Opis produktu

Sigma-Aldrich
Bromopyruvic acid, ≥98.0%
Sigma-Aldrich
2-Deoxy-D-glucose, ≥99% (GC), crystalline
Sigma-Aldrich
Carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone, ≥98% (HPLC), powder
Sigma-Aldrich
Oligomycin A, ≥99% (HPLC)
Sigma-Aldrich
Maltose solution, BioReagent, ~20% in H2O, Molecular Biology
Sigma-Aldrich
Etoposide, synthetic, 95.0-105.0%, powder
Sigma-Aldrich
Rotenone, ≥95%
Sigma-Aldrich
Paclitaxel, from Taxus yannanensis, powder
Sigma-Aldrich
Sodium oxamate, ≥98%